Skip to main content
Clinical Trials/EUCTR2017-002921-39-FR
EUCTR2017-002921-39-FRActive, not recruitingPhase 1

Comparison of motor blockade duration in the context of scheduled caesarean section with spinal anaesthesia : hyperbaric Prilocaïne versus hyperbaric Bupivacaïne. - Césarcaïne

niversity hospital of Montpellier0 sites50 target enrollmentStarted: January 12, 2018Last updated:
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
Female

Inclusion Criteria

  • - Scheduled C-section
  • - Eutocic pregnancy
  • - Non-multiple pregnancy
  • - Age : over 18-years-old
  • - Height : between 155cm and 175cm
  • - Patient affiliated or beneficiary of healthcare protection
  • - Signature of consent form
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 50
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • - Underage patient
  • - Pathological pregnancy
  • - Multiple pregnancy
  • - Emergency C-section
  • - Patient not speaking french
  • - Patient refusal
  • - spinal anaesthesia contraindication :
  • .Cutaneous infection at the injection point
  • .Coagulation disorder
  • .Lumbar equipment at needle-puncture site
  • - Prilocaïne contraindication :
  • .Allergy to Prilocaine or other amide local anaesthetic, or allergy to any excipient of BARITEKAL®
  • .Severe cardiac conduction abnormality
  • .Severe anaemia
  • .Decompensated heart failure
  • .Cardiogenic and hypovolemic shock
  • .Congenital or acquired methemoglobinemia
  • .Concomitant treatment by blood thinner
  • .Methemoglobinemia contributing factors (Dapsone, Cotrimoxazole, antimalarial treatments, nitroprusside, nitrates, nitrofurane, oxyde nitrique, 8-hydrosiquinoleine, phenacetin, phenazorydine, resercine)
  • - Bupivacaïne contraindication :
  • .Allergy to local amide anesthetic
  • .IV local anaesthesia

Investigators

Sponsor
niversity hospital of Montpellier

Similar Trials